Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1

• Laura Caleca ,

  Contributed equally to this work with: Laura Caleca, Anna Laura Putignano, Laura Papi, Paolo Radice

  * E-mail: laura.caleca@istitutotumori.mi.it

  Affiliation Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), c/o Amadeolab, Milano, Italy

  ⨯
• Anna Laura Putignano ,

  Contributed equally to this work with: Laura Caleca, Anna Laura Putignano, Laura Papi, Paolo Radice

  Affiliations Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy, FiorGen Foundation for Pharmacogenomics, Sesto Fiorentino, Italy

  ⨯
• Mara Colombo,

  Affiliation Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), c/o Amadeolab, Milano, Italy

  ⨯
• Caterina Congregati,

  Affiliation Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy

  ⨯
• Mohosin Sarkar,

  Affiliation Department of Chemistry and Department of Biochemistry, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Thomas J. Magliery,

  Affiliation Department of Chemistry and Department of Biochemistry, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Carla B. Ripamonti,

  Affiliation Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), c/o Amadeolab, Milano, Italy

  ⨯
• Claudia Foglia,

  Affiliation Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), c/o Amadeolab, Milano, Italy

  ⨯
• Bernard Peissel,

  Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  ⨯
• Daniela Zaffaroni,

  Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  ⨯
• Siranoush Manoukian,

  Affiliation Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  ⨯
• Carlo Tondini,

  Affiliation Unit of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

  ⨯
• Monica Barile,

  Affiliation Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy

  ⨯
• Valeria Pensotti,

  Affiliations COGENTECH-Cancer Genetic Testing Laboratory, Milan, Italy, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy

  ⨯
• Loris Bernard,

  Affiliations COGENTECH-Cancer Genetic Testing Laboratory, Milan, Italy, Department of Experimental Oncology, Istituto Europeo di Oncologia, Milan, Italy

  ⨯
• Laura Papi ,

  Contributed equally to this work with: Laura Caleca, Anna Laura Putignano, Laura Papi, Paolo Radice

  Affiliation Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy

  ⨯
•  [ ... ],
• Paolo Radice

  Contributed equally to this work with: Laura Caleca, Anna Laura Putignano, Laura Papi, Paolo Radice

  Affiliation Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), c/o Amadeolab, Milano, Italy

  ⨯
• [ view all ]
• [ view less ]